Infliximab

Of brand and anti-TNF compound.   May also be referred to as Remicade.

An anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis.

This concept's ID is @1~19355